Evotec SE and Indivumed GmbH announced that the companies have entered into a new research collaboration to discover and develop firstinclass therapeutics for the treatment of nonsmall cell lung cancer NSCLC The final goal of this precision medicine collaboration is to deliver highly effective treat...

Sanofi announced the successful completion of its acquisition of Synthorx Inc for per share in cash The acquisition of Synthorx perfectly aligns with our RD strategy enhancing our position as an emerging leader in the area of oncology and immunology

INHIBITOR Therapeutics Inc a biopharmaceutical company focused on the discovery development and commercialization of innovative therapeutics to inhibit progression of cancerous and noncancerous proliferation disorders today announced that the company has received Investigational New Drug IND clearan...

Genialis a leader in applied data science for the development of precision medicines today announced a collaborative partnership with Oncologie an international clinicalstage biopharma developing nextgeneration immunotherapies for cancer Initial activities will focus on the use of Genialis Expressio...

Hitachi Chemical Advanced Therapeutics Solutions LLC HCATS a US subsidiary of Hitachi Chemical Co Ltd that engages in contract manufacturing and manufacturing development of cell therapy products and Ori Biotech Ltd Ori an innovator in cell and gene therapy CGT manufacturing today announced they hav...

Ncardia and BlueRock Therapeutics today announced an agreement covering process development technologies for the manufacture of induced pluripotent stem cell iPSCderived cardiomyocytes Under the terms of the agreement Bluerock gains access to Ncardias largescale production processes and intellectual...

Crescita Therapeutics Inc a commercial dermatology company with manufacturing capabilities and a portfolio of nonprescription skincare products and prescription drug products for the treatment and care of skin conditions diseases and their symptoms today announced that it has entered into a distribu...

Neuraxpharm Group Neuraxpharm a leading European specialty pharmaceutical company focused on central nervous system CNS disorders today announces the expansion of its operations in Central Europe with the launch of Neuraxpharm Austria and the acquisition of Easypharm OTC GmbH a privatelyowned Austri...

Evoke Pharma Inc a specialty pharmaceutical company focused on treatments for gastrointestinal GI diseases and EVERSANA an independent provider of global commercial services to the life science industry today announced a collaboration to utilize EVERSANAs integrated suite of outsourced services to c...

Jazz Pharmaceuticals plc announced the submission of a New Drug Application NDA to the US Food and Drug Administration on January seeking marketing approval for JZP an investigational medicine for the treatment of cataplexy and excessive daytime sleepiness EDS in patients years of age and older...

Aruvant a clinicalstage biopharmaceutical company focused on developing and commercializing transformative therapies for the treatment of severe blood disorders today announced that the US Food and Drug Administration has granted Orphan Drug designation to ARU Aruvants investigational therapy for th...

Denovo Biopharma LLC a pioneer in applying precision medicine to develop innovative therapies today announced it has entered into an exclusive OptiontoLicense Agreement with Rumpus Therapeutics for selected indications for DB Rumpus Therapeutics gains the option to acquire an exclusive license to de...

OBI Pharma Inc a Taiwan biopharma company TPEx today announced that the US Food and Drug Administration FDA has granted Orphan Drug Designation for OBI for the treatment of Gastric Cancer OBI is a firstinclass antibody drug conjugate targeting Globo H a glycolipid antigen On December OBI was gran...